Fundraising Fox

Neurowyzr

Singapore, SG · 3 known investors

neurowyzr.com ↗

Neurowyzr provides a Digital Brain Function Screen and related clinical neuroscience tools for early detection, diagnosis, therapy, and monitoring of cognitive decline. It serves healthcare providers and pharmaceutical companies, and its screening technology is available across markets including Singapore, India, Malaysia, the UK, and the US.

Digital HealthHealthtechMedical Devices

Investors · 3

Jungle VenturesSingapore · $604K – $45M
HealthXCapitalreportedSingapore
Junglereported

In the news

Healthtech startup Neurowyzr raises $2.1M in a seed round led by Jungle Ventures, Peak XVindianstartupnews.com · Aug 2023Singapore's Neurowyzr raises additional $2.1M in seed funding co-led by Jungle Ventures and Peak XV’s Surge - TNGlobaltechnode.global · Aug 2023Backed by Peak XV and Jungle, Neurowyzr puts the focus on brain health | TechCrunchtechcrunch.com · Aug 2023Neurowyzr Raises Additional $2.1 Million In Seed Fundingindia.entrepreneur.com · Aug 2023Singapore-based Neurowyzr raises Series A funding backed by Jungle Venturesdealstreetasia.com · Jan 2023

Frequently asked questions

What does Neurowyzr do?
Neurowyzr provides a Digital Brain Function Screen and related clinical neuroscience tools for early detection, diagnosis, therapy, and monitoring of cognitive decline. It serves healthcare providers and pharmaceutical companies, and its screening technology is available across markets including Singapore, India, Malaysia, the UK, and the US.
Who are Neurowyzr's investors?
Neurowyzr's investors include Jungle Ventures, HealthXCapital, Jungle.
Where is Neurowyzr headquartered?
Neurowyzr is headquartered in Singapore, SG.